Keyphrases
Childhood Acute Lymphoblastic Leukemia
100%
Vascular Endothelial Growth factor-C (VEGF-C)
100%
Drug Responsiveness
100%
Acute Myeloid Leukemia
85%
Leukemia Cells
57%
Complete Remission
42%
Pediatric Patients
28%
Drug Exposure
28%
Vascular Endothelial Growth Factor
28%
In Vitro Resistance
28%
Treatment Protocol
14%
Leukemic Cells
14%
Bone Marrow
14%
Cell Survival
14%
Cytotoxic Drugs
14%
Blast Cells
14%
MRNA Expression
14%
Age at Diagnosis
14%
Drug Resistance
14%
Downstream Effects
14%
Cytogenetic Risk
14%
Fold Increase
14%
Cell Resistance
14%
Linear Regression Analysis
14%
Risk Profile
14%
Vascular Endothelial Growth Factor Receptor (VEGFR)
14%
Growth Factor Receptor Signaling
14%
WBC Count
14%
Cell Reduction
14%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Drug Resistance
100%
Drug Exposure
100%
Vascular Endothelial Growth Factor C
100%
Cell Survival
50%
Cytogenetics
50%
Leukocyte Count
50%
VEGF Receptors
50%
Vascular Endothelial Growth Factor
50%
Messenger RNA
50%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Vasculotropin C
100%
In Vitro
71%
Leukemia Cell
57%
Pediatrics Patient
28%
Drug Resistance
28%
Drug Exposure
28%
Linear Regression Analysis
14%
Leukocyte
14%
Cell Survival
14%
Cytotoxic Agent
14%
Vasculotropin Receptor
14%
Vasculotropin
14%
Blast Cell
14%
Sex Diagnosis
14%
Messenger RNA
14%
Neuroscience
In Vitro
100%
Myeloid
100%
Vasculotropin C
100%
In Vivo
80%
Drug Resistance
40%
Vascular Endothelial Growth Factor
20%
Cell Survival
20%
Cytogenetics
20%
Leukocyte
20%
VEGF Receptors
20%
Messenger RNA
20%
Immunology and Microbiology
Myeloid
100%
Leukemia Cell
100%
Vasculotropin C
100%
Drug Resistance
50%
Drug Exposure
50%
Vasculotropin
50%
Cell Survival
25%
Leukocyte Count
25%
Blast Cell
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Vasculotropin C
100%
Remission
42%
Drug Resistance
28%
Cytotoxic Agent
14%
Vasculotropin
14%
Vasculotropin Receptor
14%
Messenger RNA
14%